The Global Bulletproof Glass Market Continues To Grow Owing To the High Demand from Automotive Sectors Worldwide For Providing Safer Vehicles and High Revenues in the Defense Sectors

 

Bulletproof Glass Market

Bulletproof glass is an extremely tough and optically clear material that is especially resistant to penetration by bullets. However, like any complex material, it is not entirely impenetrable. Bulletproof safety glass has also been designed to protect against the impact of exploding gas bottles or fireworks. The laminated glass used in this type of product is usually made of acrylic plastic. This plastic coating provides the necessary protection against the shards of shattered glass. It is used for a variety of purposes, including bullet-resistant safety glasses for vehicles and personal protection. As it can withstand a tremendous amount of force, the transparent armor is an important addition to the arsenal of security products available to consumers. Another advantage of using acrylic plastic as a material is that it is flame resistant, which will make it suitable for use in various applications.

Market Dynamics

Major factors influencing in bulletproof glass market growth include rising concerns on the wellbeing and security of people as the world is witnessing increased cases of terrorist attacks, robberies, and thefts. The market is also determined by federal guidelines, which guarantee extreme security to financial institutions, vehicles used for government purposes, and federal and defense institutes. High military revenues from nations such as the U.S., Saudi Arabia, India, China, etc., have resulted in the increased demand in the bulletproof glass market. For instance, according to data published by U.S. Government, in 2019, the military budget of the nation was around US$ 675 billion. Increased R&D in producing armors that are more efficient also has a positive influence on the market. The main factor hindering growth of the bulletproof glass market is the dormant or declining defense budget plans in some of the emerging economies of the world.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these, North America is estimated to hold a bigger share of the bulletproof glass market owing to the increased demand from the automotive sector in the region. Automobile manufacturers such as Volkswagen, Audi, Ford, and BMW are launching bulletproof vehicles which are expected to augment growth of the market. For instance, in 2020, Audi launched its A8 L Security, which the company claims is not just a car but a safe fortress on the wheels, owing to the durability and bullet resisting power of the vehicle. The increase in defense revenue and the presence of key players in the region are influencing growth of the bulletproof glass market.

Competitive Analysis

Major players operating in the bulletproof glass market include Asahi Glass Co. Ltd. (AGC Inc.), Saint-Gobain, Nippon Sheet Glass Co. Ltd., Taiwan Glass Industry Corporation, Guardian Glass LLC, SCHOTT AG, Scheuten, Consolidated Glass Holdings, Inc., and Phoenicia.

In March 2020, Range Rover launched the 2020 Range Rover Sentinel, which is said to be able to withstand attacks from major weapons such as AK-47s and pipe bombs.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more